ReviewLeukemia2024

Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy.

Tao Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.